# Valgen Infosystem Pvt.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/valgen-infosystem-pvt

- Industry: Business Support Services
- Headquarters: Chennai, India
- Website: www.valgeninc.com
- Total disclosed funding: $0.4M
- Latest round: Angel (Jun 29, 2012)
- Investors on record: 1

## About

Valgen Infosystem Pvt. Ltd. is a biotechnology firm focused on delivering innovative solutions in genetic research, therapeutic development, and diagnostic tools to enhance healthcare outcomes.Founded by Hariharan B, Valgen Infosystem Pvt. Ltd. operates from Chennai, India, specializing in advanced biotechnology solutions. The company raised INR 22.5 million in Angel funding led by Blume Ventures on June 29, 2012, and has engaged in one total deal to date.Valgen Inc. specializes in the development and delivery of advanced biotechnology solutions, focusing on genetic research, therapeutic innovations, and diagnostic tools. Their core offerings are designed to address complex challenges in healthcare and life sciences, providing products that enhance research efficiency and accuracy. This includes proprietary assays for genetic testing, custom synthesis of nucleic acids, and bioinformatics support services that aid in data analysis and interpretation. Valgen Inc. serves a diverse clientele across North America, Europe, and Asia-Pacific markets, accelerating drug development processes and enabling personalized medicine.Valgen Inc. generates revenue through a multi-faceted transaction structure that includes direct sales to research institutions and partnerships with healthcare organizations. The company reported a revenue of INR 0 mn and an EBITDA of INR -75,503.9 in the most recent year, 2023. They offer subscription-based access to proprietary software tools and a tiered pricing model for their diagnostic products, fostering stable revenue streams through long-term contracts with clients and collaborations with pharmaceutical companies for custom solutions.Valgen Infosystem Pvt. Ltd. aims to launch several new biotechnology products designed to enhance genetic research methodologies, with specific release dates yet to be announced. The company plans to expand its market reach into additional regions within Asia-Pacific by the end of 2025, leveraging the recent funding of INR 22.5 million raised in June 2012 to support these initiatives and further develop their product offerings.

## Funding rounds

- Angel, Jun 29, 2012, $0.4M — Blume Ventures

## Investors

- Blume Ventures (https://capitalatlas.ai/funds/blume-ventures) — Angel